🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6197754

    Suppression of tumor growth by a mini-E1A gene

    The Board of Regents of the University of Texas System · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6193963

    Method of treating tumor-bearing patients with human plasma hyaluronidase

    The Regents of the University of California · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6187306

    Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6187313

    Composition and method for treating and preventing helicobactor-pylori-associated stomach gastritis, ulcers and cancer

    Nature's Sunshine Products, Inc. · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6184224

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6183727

    Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

    THE ARIZONA BOARD OF REGENTS · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6172212

    Pea3 is a tumor suppressor

    The Board of Regents of the University of Texas System · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6165440

    Radiation and nanoparticles for enhancement of drug delivery in solid tumors

    The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6162897

    17q-linked breast and ovarian cancer susceptibility gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6160184

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6156321

    Tissue factor methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6155266

    Method for treatment of cancer and infectious disease

    Maxim Pharmaceuticals, Inc. · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6153430

    Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6150398

    Methods for the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6149918

    Human herpesvirus type 8 isolated from human lymphoma cell line

    The Regents of the University of California · Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6149904

    Method for inhibiting tumor cell growth by administering to tumor cells expressing a nucleic acid encoding a connexin and a pro-drug

    The Regents of the University of California · Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6147060

    Treatment of carcinomas using squalamine in combination with other anti-cancer agents

    Magainin Pharmaceuticals Inc. · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6143290

    Tumor regression by adenovirus expression of wild-type p53

    The Board of Regents of the University of Texas System · Granted Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6136306

    Method for treating tumors

    The Regents of the University of California · Granted Tue Oct 24 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6132715

    Method of inhibiting biosynthesis of tumor necrosis factor

    Nika Health Products Limited · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6132980

    Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6132730

    Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6132729

    Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6129914

    Bispecific antibody effective to treat B-cell lymphoma and cell line

    Protein Design Labs, Inc. · Granted Tue Oct 10 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6123941

    Method for restoration of normal phenotype in cancer cells

    The Regents of the University of California · Granted Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6114397

    Gossypol for the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6114110

    Isolation and propagation of a human herpesvirus derived from AIDS-associated Kaposi's sarcoma cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6110889

    Peptide tumor cell growth inhibitors

    The Board of Regents of the University of Texas System · Granted Tue Aug 29 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6107540

    Mice models of human prostate cancer progression

    The Regents of the University of California · Granted Tue Aug 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6096534

    Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6096520

    Brain glycogen phosphorylase cancer antigen

    The Regents of the University of California · Granted Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6090795

    Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6090365

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6087110

    Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6084069

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6083703

    Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6071949

    Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6069283

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6060310

    Transcription factor decoy and tumor growth inhibitor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6060505

    Method of treating cancer using C-26 modified bryostatin

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6057300

    Methods for treating cancers and restenosis with p21

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6051230

    Compositions for targeting the vasculature of solid tumors

    The Board of Regents of the University of Texas System · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6051218

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6051229

    Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions

    The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6051387

    Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies

    The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6045789

    Bystander effect tumoricidal therapy by expressing an HSV-tk gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6046241

    .beta.-alethine as anti-tumor agent

    The Regents of the University of New Mexico · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6042829

    Biotherapy of cancer by targeting TP-3/P80

    Regents of the University of Minnesota · Granted Tue Mar 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.